Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lymphomas

Clinical Trial at: Texas Oncology - San Antonio

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 with or without Bendamustine and TGR-1202 alone in Patients with Previously Treated Non-Hodgkin’s Lymphoma (UTX-TGR-205)

  • Details

ClinicalTrials.gov ID: NCT02793583
Diagnosis Type: Non-Hodgkins
USOR Number: 16065

  • Practice Details

5206 Research Dr
San Antonio, Texas 75204
546.95 mi. away
P: (210) 595-5300

More Details View Practice Page

Renal Cancer

Clinical Trial at: Texas Oncology - San Antonio

(AB928CSP0005) A Phase 1 Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants with Advanced Malignancies

  • Details

ClinicalTrials.gov ID: NCT03629756
Diagnosis Type: NA
USOR Number: 18235

  • Practice Details

5206 Research Dr
San Antonio, Texas 75204
546.95 mi. away
P: (210) 595-5300

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Texas Oncology - San Antonio

3000-03-005/ENGOT-OV44 : A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERAPY WITH TSR-042 AND NIRAPARIB VERSUS STANDARD OF CARE PLATINUM-BASED THERAPY AS FIRST-LINE TREATMENT OF STAGE III OR IV NONMUCINOUS EPITHELIAL OVARIAN CANCER

  • Details

ClinicalTrials.gov ID: NCT03602859
Diagnosis Type: NA
USOR Number: 17218

  • Practice Details

5206 Research Dr
San Antonio, Texas 75204
546.95 mi. away
P: (210) 595-5300

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Texas Oncology - San Antonio

Clovis CO-338-087/GOG-3020/ENGOT-ov45/NCRI/ATHENA: A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03522246
Diagnosis Type: NA
USOR Number: 17182

  • Practice Details

5206 Research Dr
San Antonio, Texas 75204
546.95 mi. away
P: (210) 595-5300

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - San Antonio

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

5206 Research Dr
San Antonio, Texas 75204
546.95 mi. away
P: (210) 595-5300

More Details View Practice Page

Solid Tumors

Clinical Trial at: Texas Oncology - San Antonio

(AB928CSP0005) A Phase 1 Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants with Advanced Malignancies

  • Details

ClinicalTrials.gov ID: NCT03629756
Diagnosis Type: NA
USOR Number: 18235

  • Practice Details

5206 Research Dr
San Antonio, Texas 75204
546.95 mi. away
P: (210) 595-5300

More Details View Practice Page

Cervical Cancer

Clinical Trial at: Texas Oncology - San Antonio

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Chemotherapy Plus Placebo for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer(KEYNOTE-826) (MK3475-826)

  • Details

ClinicalTrials.gov ID: NCT03635567
Diagnosis Type: NA
USOR Number: 18032

  • Practice Details

5206 Research Dr
San Antonio, Texas 75204
546.95 mi. away
P: (210) 595-5300

More Details View Practice Page

Peritoneal Cancer

Clinical Trial at: Texas Oncology - San Antonio

Clovis CO-338-087/GOG-3020/ENGOT-ov45/NCRI/ATHENA: A Multicenter, Randomized, Double-Blind, Placebo Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03522246
Diagnosis Type: NA
USOR Number: 17182

  • Practice Details

5206 Research Dr
San Antonio, Texas 75204
546.95 mi. away
P: (210) 595-5300

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - San Antonio

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

5206 Research Dr
San Antonio, Texas 75204
546.95 mi. away
P: (210) 595-5300

More Details View Practice Page

Myelomas

Clinical Trial at: Texas Oncology - San Antonio

C16038: An Open-Label, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Ixazomib (NINLARO®) in Combination with Lenalidomide and Dexamethasone (IRD) in Patients with Multiple Myeloma Previously Receiving a Bortezomib-Based Triplet Induction Regimen (Phase IV)

  • Details

ClinicalTrials.gov ID: NCT03173092
Diagnosis Type: NA
USOR Number: 17081

  • Practice Details

5206 Research Dr
San Antonio, Texas 75204
546.95 mi. away
P: (210) 595-5300

More Details View Practice Page

Myelofibrosis

Clinical Trial at: Texas Oncology - San Antonio

INCB 39110-209, An Open-Label Phase 2 Study of Itacitinib (INCB039110) in Combination With Low-Dose Ruxolitinib or Itacitinib Alone Following Ruxolitinib in Subjects With Myelofibrosis

  • Details

ClinicalTrials.gov ID: NCT03144687
Diagnosis Type: NA
USOR Number: 17085

  • Practice Details

5206 Research Dr
San Antonio, Texas 75204
546.95 mi. away
P: (210) 595-5300

More Details View Practice Page

Lymphomas

Clinical Trial at: Texas Oncology - San Antonio

A Phase 2, Open-Label, 2-Cohort, Multicenter Study of INCB050465, a PI3Kä Inhibitor, in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a BTK Inhibitor (CITADEL-205)- INCB050465-205

  • Details

ClinicalTrials.gov ID: NCT03235544
Diagnosis Type: Non-Hodgkins
USOR Number: 17093

  • Practice Details

5206 Research Dr
San Antonio, Texas 75204
546.95 mi. away
P: (210) 595-5300

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - San Antonio

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Practice Details

5206 Research Dr
San Antonio, Texas 75204
546.95 mi. away
P: (210) 595-5300

More Details View Practice Page

Leukemia

Clinical Trial at: Texas Oncology - San Antonio

(UTX-TGR-204) A Multi-Center, Open-Label, Compassionate Use Extension Study of Ublituximab (TG-1101) in Combination with Umbralisib (TGR-1202) for Patients Previously Enrolled in Protocol UTX-TGR-304

  • Details

ClinicalTrials.gov ID: NCT02656303
Diagnosis Type: CLL
USOR Number: 16213

  • Practice Details

5206 Research Dr
San Antonio, Texas 75204
546.95 mi. away
P: (210) 595-5300

More Details View Practice Page

Hematologic

Clinical Trial at: Texas Oncology - San Antonio

Paroxysmal Nocturnal Hemoglobinuria (PNH) Registry (M07-001)

  • Details

ClinicalTrials.gov ID: NCT01374360
Diagnosis Type: NA
USOR Number: 08160

  • Practice Details

5206 Research Dr
San Antonio, Texas 75204
546.95 mi. away
P: (210) 595-5300

More Details View Practice Page

Thyroid Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Longmont

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

2030 Mountain View Dr, Suite 210
Longmont, Colorado 80501
550.39 mi. away
P: (303) 684-1900

More Details View Practice Page

Gastric Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Longmont

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

2030 Mountain View Dr, Suite 210
Longmont, Colorado 80501
550.39 mi. away
P: (303) 684-1900

More Details View Practice Page

Ovarian Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Longmont

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

2030 Mountain View Dr, Suite 210
Longmont, Colorado 80501
550.39 mi. away
P: (303) 684-1900

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Longmont

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

2030 Mountain View Dr, Suite 210
Longmont, Colorado 80501
550.39 mi. away
P: (303) 684-1900

More Details View Practice Page

Pancreatic Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Longmont

CA209848 - A Randomized, Open-Label, Phase 2 Study of Nivolumab in Combination with Ipilimumab or Nivolumab Monotherapy in Participants with Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H)

  • Details

ClinicalTrials.gov ID: NCT03668119
Diagnosis Type: NA
USOR Number: 16240

  • Practice Details

2030 Mountain View Dr, Suite 210
Longmont, Colorado 80501
550.39 mi. away
P: (303) 684-1900

More Details View Practice Page

Pages